![Mary Sheahan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Sheahan
Directeur/Membre du Conseil chez CENTOGENE N.V.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Peer Schatz | M | 57 | 4 ans | |
Hubert Birner | M | 57 | 7 ans | |
Peter Bauer | M | 54 | 8 ans | |
Guido Prehn | M | 46 | 5 ans | |
Miguel Coego Rios | M | - | 2 ans | |
John Bradshaw | M | 60 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
Eric Souêtre | M | 68 | 7 ans | |
Jonathan Sheldon | M | 52 | 4 ans | |
Lennart Streibel | M | - | - | |
Allison Jeynes-Ellis | M | 58 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 12 ans |
Bettina Goerner | F | - | - | |
Anna Danilewicz | F | - |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
Frank Volpers | M | - | 9 ans | |
Daniela Osterholz | F | - | 12 ans | |
Kurt C. Wheeler | M | 71 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
Ian Rentsch | M | - | 1 ans | |
Ted Love | M | 65 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 11 ans |
Kim Stratton | F | 62 | 3 ans | |
Genghis Lloyd-Harris | M | 67 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
Anders Gersel Pedersen | M | 73 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 5 ans |
James Reddoch | M | 54 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 10 ans |
David Chiswell | M | 70 |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 5 ans |
Ben Legg | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Berndt A. E. Modig | M | 65 | 5 ans | |
Flemming Ørnskov | M | 66 | 4 ans | |
Holger Friedrich | M | 57 | 6 ans | |
Florian Vogel | M | - | 8 ans | |
Andreas Busch | M | 59 | 1 ans | |
Robert W. de Deugd | M | - | - | |
Patrice P. Denefle | M | 64 | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Allemagne | 21 | 70,00% |
Royaume-Uni | 9 | 30,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mary Sheahan
- Réseau Personnel